WuXi Biologics (Cayman) Inc. (WXIBF) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    WuXi Biologics (Cayman) I...

    OTC: WXIBF · Real-Time Price · USD
    5.61
    0.25 (4.66%)
    At close: Oct 03, 2025, 1:09 PM
    5.36
    -4.39%
    After-hours: Oct 02, 2025, 12:07 PM EDT

    WuXi Biologics (Cayman) Cash Flow Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Net Income
    		 5.67B 4.83B 3.2B 3.4B 3.59B 5.36B 5.02B 3.39B 2.79B
    Depreciation & Amortization
    		 1.51B 1.44B 1.37B 1.17B 884.41M 800.67M 650.61M 481.78M 421.28M
    Stock-Based Compensation
    		 994.3M 1.22B 1.33B 1.27B 1.33B 1.3B 954.84M 577.95M 378.45M
    Other Working Capital
    		 -1.16B -1.16B -150.57M -301.13M -250.71M -476.35M -927.99M -551.77M 4.23M
    Other Non-Cash Items
    		 -1.65B -1.47B -1.81B -279.1M 3.16B -876.68M -818.64M 1.76B 756.12M
    Deferred Income Tax
    		 n/a n/a n/a n/a 1.3B n/a -1.3B n/a 2.32B
    Change in Working Capital
    		 -800.5M -800.5M -448.17M -896.35M -2.55B -974.47M -1.65B -2.78B -2.1B
    Operating Cash Flow
    		 5.72B 5.22B 3.64B 4.67B 6.42B 5.54B 4.09B 3.43B 2.25B
    Capital Expenditures
    		 -3.96B -3.93B -3.98B -4.23B -5.3B -5.87B -5.12B -6.51B -7.18B
    Cash Acquisitions
    		 n/a n/a n/a n/a -1.04M -131.49M -275.81M -2.18B -2.19B
    Purchase of Investments
    		 -11.43B -11.43B -7.54B -15.08B -7.54B -10.77B -10.77B n/a n/a
    Sales Maturities Of Investments
    		 10.89B 10.89B 7.82B 15.64B 7.82B 10.49B 10.49B n/a n/a
    Other Investing Acitivies
    		 401.63M 524.28M 1.62B 261.99M -229.54M 377.56M 1.46B -913.26M -1.55B
    Investing Cash Flow
    		 -4.1B -3.94B -2B -3.23B -5.16B -5.91B -4.22B -9.6B -10.93B
    Debt Repayment
    		 492.19M 420.59M -478.73M -818.45M -409.23M -295.02M -295.02M n/a n/a
    Common Stock Repurchased
    		 -1.56B -1.77B -1.69B -916.92M -2.57B -2.8B -3.21B -2.52B n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 -1.31B -1.42B 2.85B 4.87B 1.59B 507.88M 278.17M 10.73B 16.74B
    Financial Cash Flow
    		 -2.36B -2.75B 673.62M 3.13B -1.39B -2.59B -3.23B 8.21B 16.74B
    Net Cash Flow
    		 16.98B 8.28B 3.02B 6.55B 2.4B -3.48B -3.75B -906.47M 1.93B
    Free Cash Flow
    		 1.76B 1.29B -346.67M 437.2M 1.12B -326.72M -1.03B -3.08B -4.94B

    Add to Watchlist